12 September 1997
Immunophenotyping fish-to-mouse islet xenograft rejection: a time course study
James R Wright, Heather Kearns, Hua Yang, Robert B Fraser, Pat Colp, Geoff RowdenAnn Transplant 1997; 2(3): 12-16 :: ID: 497167
Abstract
Tilapia islets. Brockmann bodies (BBs), transplanted under the kidney capsule (KC) of diabetic nude mice provide long-term normoglycemia, but, when transplanted into euthymic mice, reject in about one week. Objectives: The present study characterizes the cellular infiltrates at several time points during the xenograft rejection process. Methods: Tilapia BBswere harvested, fragmented, cultured overnight, and then transplanted under the KC of streptozotocindiabetic Balb/c mice. Glucose levels were measured daily until the mice were killed at I (n=2), 2 (n=2), 3 (n=3), and 5 days (n=3) post transplantation and at the time of BBgraft rejection (n=6). Serial frozen sections of graft-bearing kidneys were stained for murine macrophages (MOMA-2, F4/S0, M170), CD4+ (L3T4) T-cells (YTS 191.1), and CDS+ (Ly-2) T-cells (YTS 169.4) by indirect immunoperoxidase; the presence of granulocytes and plasma cells was assessed with H&E stained sections. Results: At I day, the grafts have undergone some central necrosis with macrophage infiltration. By 2 days, these changes are very well-developed and granulocytes, almost exclusively eosinophils, begin to surround the graft. At 3 days, rare CD4+ and CDS+ T-cells are seen at the graft kidney interface. Macrophages massively infiltrate the necrotic foci and pepper the graft. At 5 days and at rejection, macrophages and eosinophils predominated in the center of rejecting grafts while CDS+ T-cells and CD4+ T-cells were present at the periphery. Plasma cells were rare. Conclusion: We conclude that cell-mediated processes and eosinophils play roles in the rejection of cellular xenografts across this very wide phylogenetic barrier.
Keywords: Islets, Cell Transplantation, Graft Rejection, macrophage, CDBT-Iymphocyte, discordant, Xenotransplantation
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






